These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19167063)

  • 1. 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro.
    Li Q; Yu K; Tian X; Kong F; You Y; Chen Z; Zou P
    Leuk Res; 2009 Sep; 33(9):1266-71. PubMed ID: 19167063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
    Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
    Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
    Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of the osteoclast in pathogenesis of multiple myeloma].
    Zhang JH; Fu JX; Zhang XH; Sun Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):323-6. PubMed ID: 17877161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of whey protein on the proliferation and differentiation of osteoblasts.
    Xu R
    J Dairy Sci; 2009 Jul; 92(7):3014-8. PubMed ID: 19528578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
    Son E; Do H; Joo HM; Pyo S
    Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct effects of osteoprotegerin on human bone cell metabolism.
    Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
    Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
    Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
    Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells.
    Benedikt MB; Mahlum EW; Shogren KL; Subramaniam M; Spelsberg TC; Yaszemski MJ; Maran A
    J Cell Biochem; 2010 Apr; 109(5):950-6. PubMed ID: 20082321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Kruger MC
    J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.
    Bolzoni M; Storti P; Bonomini S; Todoerti K; Guasco D; Toscani D; Agnelli L; Neri A; Rizzoli V; Giuliani N
    Exp Hematol; 2013 Apr; 41(4):387-97.e1. PubMed ID: 23178378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
    De Wilde A; Lieberherr M; Colin C; Pointillart A
    J Cell Physiol; 2004 Aug; 200(2):253-62. PubMed ID: 15174095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.
    Singh PP; van der Kraan AG; Xu J; Gillespie MT; Quinn JM
    Biochem Biophys Res Commun; 2012 May; 422(1):48-53. PubMed ID: 22561018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures.
    Huang L; Cheng YY; Koo PL; Lee KM; Qin L; Cheng JC; Kumta SM
    J Biomed Mater Res A; 2003 Sep; 66(4):880-4. PubMed ID: 12926041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
    Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
    J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor.
    Karadag A; Scutt AM; Croucher PI
    J Bone Miner Res; 2000 Oct; 15(10):1935-43. PubMed ID: 11028445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts.
    Giner M; Montoya MJ; Vázquez MA; Rios MJ; Moruno R; Miranda MJ; Pérez-Cano R
    Horm Metab Res; 2008 Dec; 40(12):869-74. PubMed ID: 18932123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.